Long-term survival in patients with advanced non–small-cell...

European Journal of Cancer 2019 / 01 Vol. 107

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

von Pawel, J., Bordoni, R., Satouchi, M., Fehrenbacher, L., Cobo, M., Han, J.Y., Hida, T., Moro-Sibilot, D., Conkling, P., Gandara, D.R., Rittmeyer, A., Gandhi, M., Yu, W., Matheny, C., Patel, H., San
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
107
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.11.020
Date:
January, 2019
File:
PDF, 905 KB
english, 2019
Conversion to is in progress
Conversion to is failed